Clinical Trial Update: A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin

View source ↗

Summary

A completed clinical trial using Japanese medical records evaluated bleeding events in atrial fibrillation patients with coronary artery disease who initiated d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Rivaroxaban (rivaroxaban)
• Warfarin (warfarin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Coronary Artery Disease, Atrial Fibrillation | Status: COMPLETED | Results posted: 2024-03-07